このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Sopharma AD マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Ognian Donev
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 23.9yrs |
CEOの所有権 | 8.8% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 9.7yrs |
経営陣の近況
Recent updates
Sopharma AD's (BUL:SFA) Problems Go Beyond Weak Profit
Sep 07Here's Why Sopharma AD (BUL:SFA) Can Manage Its Debt Responsibly
Jun 02Sopharma AD (BUL:SFA) Has A Somewhat Strained Balance Sheet
Apr 09Here's Why We Think Sopharma AD (BUL:3JR) Is Well Worth Watching
Feb 20How Many Sopharma AD (BUL:3JR) Shares Do Institutions Own?
Feb 05Should You Rely On Sopharma AD's (BUL:3JR) Earnings Growth?
Jan 22Sopharma AD (BUL:3JR) Has A Somewhat Strained Balance Sheet
Jan 06Sopharma AD (BUL:3JR) Share Prices Have Dropped 25% In The Last Three Years
Dec 22Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Dec 07Are Investors Undervaluing Sopharma AD (BUL:3JR) By 29%?
Nov 19Should Sopharma AD (BUL:3JR) Be Part Of Your Dividend Portfolio?
Jul 07CEO(最高経営責任者
Ognian Donev (67 yo)
23.9yrs
在職期間
лв723,162
報酬
Mr. Ognian Ivanov Donev, D.Sc. (Econ.), Ph D., serves as the Executive Chairman at Sopharma AD and Sopharma Trading AD and also served as Chief Executive Officer since September 2021 until November 2021. M...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman | 23.9yrs | лв723.16k | 8.76% BGN 86.3m | |
Deputy Chairman | no data | лв173.75k | 0.000090% BGN 886.0 | |
Director | 6.1yrs | лв252.59k | 0.0012% BGN 12.0k | |
Independent Director | 13.3yrs | лв120.00k | 0.27% BGN 2.6m | |
Director | 3.3yrs | データなし | 0.021% BGN 203.2k |
9.7yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: SFAの 取締役会 は 経験豊富 であると考えられます ( 9.6年の平均在任期間)。